Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annie Fourrier

Showing results (1-10 of 108) with videos related to

Pageof 11
Sort By:
Archives of Internal Medicine|June 12, 2013
Study findings hard to interpret-replyAntoine Pariente, Annie Fourrier-Réglat, Yola Moride
British Journal of Clinical Pharmacology|November 26, 2002
Does age increase the risk of adverse drug reactions?Bernard Bégaud, Karin Martin, Annie Fourrier, et al.
Therapie|March 25, 2006
Incidence and characteristics of benzodiazepine use in an elderly cohort: the EVA studyNathalie Lechevallier-Michel, Claudine Berr, Annie Fourrier-Réglat
European Journal of Clinical Pharmacology|October 21, 2003
The delusion of reducing sample sizeBernard Bégaud, Annie Fourrier, Nicholas Moore, et al.
BMC Pharmacology & Toxicology|June 2, 2018
Assessment of the state of pharmacovigilance in the South-South zone of Nigeria using WHO pharmacovigilance indicatorsAbimbola O Opadeyi, Annie Fourrier-Réglat, Ambrose O Isah
Therapeutic Advances in Drug Safety|February 6, 2019
Educational intervention to improve the knowledge, attitude and practice of healthcare professionals regarding pharmacovigilance in South-South NigeriaAbimbola O Opadeyi, Annie Fourrier-Réglat, Ambrose O Isah
Diabetes Research and Clinical Practice|March 13, 2018
Impact of cancer diagnosis on persistence of oral antidiabetic drugsLouis Létinier, Yohann Mansiaux, Antoine Pariente, et al.
Presse Medicale (Paris, France : 1983)|November 21, 2018
[Use and misuse of benzodiazepines in patients with psychiatric disorders]Arnaud Panes, Annie Fourrier-Réglat, Hélène Verdoux, et al.
Drug Safety|September 18, 2007
Impact of safety alerts on measures of disproportionality in spontaneous reporting databases: the notoriety biasAntoine Pariente, Fleur Gregoire, Annie Fourrier-Reglat, et al.
IEEE Transactions on Information Technology in Biomedicine : a Publication of the IEEE Engineering in Medicine and Biology Society|December 29, 2005
Evaluation of statistical association measures for the automatic signal generation in pharmacovigilanceEmmanuel Roux, Frantz Thiessard, Annie Fourrier, et al.
Pageof 11

Showing results (1-10 of 108) with videos related to

Sort By:
Pageof 11
Archives of Internal Medicine|June 12, 2013
Study findings hard to interpret-replyAntoine Pariente, Annie Fourrier-Réglat, Yola Moride
British Journal of Clinical Pharmacology|November 26, 2002
Does age increase the risk of adverse drug reactions?Bernard Bégaud, Karin Martin, Annie Fourrier, et al.
Therapie|March 25, 2006
Incidence and characteristics of benzodiazepine use in an elderly cohort: the EVA studyNathalie Lechevallier-Michel, Claudine Berr, Annie Fourrier-Réglat
European Journal of Clinical Pharmacology|October 21, 2003
The delusion of reducing sample sizeBernard Bégaud, Annie Fourrier, Nicholas Moore, et al.
BMC Pharmacology & Toxicology|June 2, 2018
Assessment of the state of pharmacovigilance in the South-South zone of Nigeria using WHO pharmacovigilance indicatorsAbimbola O Opadeyi, Annie Fourrier-Réglat, Ambrose O Isah
Therapeutic Advances in Drug Safety|February 6, 2019
Educational intervention to improve the knowledge, attitude and practice of healthcare professionals regarding pharmacovigilance in South-South NigeriaAbimbola O Opadeyi, Annie Fourrier-Réglat, Ambrose O Isah
Diabetes Research and Clinical Practice|March 13, 2018
Impact of cancer diagnosis on persistence of oral antidiabetic drugsLouis Létinier, Yohann Mansiaux, Antoine Pariente, et al.
Presse Medicale (Paris, France : 1983)|November 21, 2018
[Use and misuse of benzodiazepines in patients with psychiatric disorders]Arnaud Panes, Annie Fourrier-Réglat, Hélène Verdoux, et al.
Drug Safety|September 18, 2007
Impact of safety alerts on measures of disproportionality in spontaneous reporting databases: the notoriety biasAntoine Pariente, Fleur Gregoire, Annie Fourrier-Reglat, et al.
IEEE Transactions on Information Technology in Biomedicine : a Publication of the IEEE Engineering in Medicine and Biology Society|December 29, 2005
Evaluation of statistical association measures for the automatic signal generation in pharmacovigilanceEmmanuel Roux, Frantz Thiessard, Annie Fourrier, et al.
Pageof 11